NCT01125449 2025-05-18Study of High Dose Intravenous (IV) Ascorbic Acid in Measurable Solid Tumor DiseaseSitus Cancer Research CenterPhase 2 Withdrawn
NCT02223052 2020-05-12Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic MalignanciesCelgenePhase 1 Completed89 enrolled